Vanguard Capital Management »

20/20 Biolabs shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of 20/20 Biolabs (AIDX) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in 20/20 Biolabs

Tip: Access up to 7 years of quarterly data

All positions including 20/20 Biolabs held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 20/20 Biolabs by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $14k 25k 0.55

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)

View all positions for Vanguard Capital Management

Top funds holding 20/20 Biolabs

Cresset Asset Management
Hrt Financial
Vanguard Fiduciary Trust
Geode Capital Management
Union Bankshares
Vanguard Capital Management
Citadel Advisors
Bank of America Corporation
Susquehanna International
Mcdonald Partners
Signature
Hanson McClain Advisors
Toth Financial Advisory Corporation
UBS Group

View all funds holding 20/20 Biolabs